Tempest Therapeutics, Inc. Cash Equivalents, at Carrying Value
Tempest Therapeutics, Inc. (TPST) had Cash Equivalents, at Carrying Value of $8.90 million as of 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashEquivalentsAtCarryingValue · last filed 2013-05-15
- 2013-03-31: Cash Equivalents, at Carrying Value $8.90M.
- 2012-12-31: Cash Equivalents, at Carrying Value $13.30M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2013-03-31 | $8.90M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $13.30M 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |